tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Syntara Limited Reports Promising Phase 2a Results for Amsulostat in Myelofibrosis
Company AnnouncementsSyntara Limited Reports Promising Phase 2a Results for Amsulostat in Myelofibrosis
4d ago
Syntara Limited Announces 2025 Virtual AGM
PremiumCompany Announcements
Syntara Limited Announces 2025 Virtual AGM
11d ago
Syntara Limited Announces Virtual AGM for 2025
PremiumCompany Announcements
Syntara Limited Announces Virtual AGM for 2025
1M ago
Pharmaxis Ltd Announces Positive Phase 2a Results for Amsulostat in Myelofibrosis
PremiumCompany Announcements
Pharmaxis Ltd Announces Positive Phase 2a Results for Amsulostat in Myelofibrosis
1M ago
Syntara Limited Reports Promising Phase 2a Results for Amsulostat in Myelofibrosis Treatment
PremiumCompany Announcements
Syntara Limited Reports Promising Phase 2a Results for Amsulostat in Myelofibrosis Treatment
1M ago
Syntara Strengthens Leadership for Amsulostat Development
PremiumCompany AnnouncementsSyntara Strengthens Leadership for Amsulostat Development
1M ago
Syntara Limited Secures A$5.6 Million R&D Tax Incentive
Premium
Company Announcements
Syntara Limited Secures A$5.6 Million R&D Tax Incentive
1M ago
Pharmaxis Ltd Highlights Strategic Initiatives at Healthcare Conference
Premium
Company Announcements
Pharmaxis Ltd Highlights Strategic Initiatives at Healthcare Conference
2M ago
Pharmaxis Receives FDA Guidance on Amsulostat’s Clinical Pathway
PremiumCompany Announcements
Pharmaxis Receives FDA Guidance on Amsulostat’s Clinical Pathway
2M ago
Syntara Limited Enhances Corporate Governance Framework
PremiumCompany Announcements
Syntara Limited Enhances Corporate Governance Framework
2M ago
Syntara Limited Affirms Governance Compliance for FY2025
PremiumCompany Announcements
Syntara Limited Affirms Governance Compliance for FY2025
2M ago
Pharmaxis Ltd Releases Annual Financial Report for 2025
PremiumCompany Announcements
Pharmaxis Ltd Releases Annual Financial Report for 2025
2M ago
Syntara Limited Reports Improved Financial Performance for 2025
PremiumCompany AnnouncementsSyntara Limited Reports Improved Financial Performance for 2025
2M ago
Syntara Limited to Quote New Securities on ASX
Premium
Company Announcements
Syntara Limited to Quote New Securities on ASX
2M ago
Pharmaxis Ltd Discusses Syntara’s Future Prospects and Risks
Premium
Company Announcements
Pharmaxis Ltd Discusses Syntara’s Future Prospects and Risks
2M ago
Syntara Limited to Host Investor Webinar on Amsulostat Development
PremiumCompany Announcements
Syntara Limited to Host Investor Webinar on Amsulostat Development
3M ago
Syntara Receives FDA Guidance on Amsulostat Development for Myelofibrosis
PremiumCompany Announcements
Syntara Receives FDA Guidance on Amsulostat Development for Myelofibrosis
3M ago
Syntara Limited Announces New Securities Issuance
PremiumCompany Announcements
Syntara Limited Announces New Securities Issuance
3M ago
Syntara Limited Resumes Trading on ASX
PremiumCompany Announcements
Syntara Limited Resumes Trading on ASX
3M ago
Syntara Limited Proposes CEO Performance Rights Issuance
PremiumCompany AnnouncementsSyntara Limited Proposes CEO Performance Rights Issuance
3M ago
Pharmaxis Ltd Releases Quarterly Update on Strategic Developments
Premium
Company Announcements
Pharmaxis Ltd Releases Quarterly Update on Strategic Developments
3M ago
Syntara Limited Schedules Investor Webinar Amidst Quarterly Update
Premium
Company Announcements
Syntara Limited Schedules Investor Webinar Amidst Quarterly Update
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >